Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 275

1.

Systematic review of blood transcriptome profiling in neuropsychiatric disorders: guidelines for biomarker discovery.

Breen MS, Stein DJ, Baldwin DS.

Hum Psychopharmacol. 2016 Sep;31(5):373-81. doi: 10.1002/hup.2546. Review.

PMID:
27650405
2.

The separation of adult separation anxiety disorder.

Baldwin DS, Gordon R, Abelli M, Pini S.

CNS Spectr. 2016 Aug;21(4):289-94. doi: 10.1017/S1092852916000080.

PMID:
27503572
3.

Authors' Reply to Alain Braillon's Comment on "Safety and Tolerability of Pharmacological Treatment of Alcohol Dependence: Comprehensive Review of Evidence".

Sinclair JM, Chambers SE, Baldwin DS.

Drug Saf. 2016 Aug 8. [Epub ahead of print] No abstract available.

PMID:
27503285
4.

A meta-analysis of the efficacy of vortioxetine in patients with major depressive disorder (MDD) and high levels of anxiety symptoms.

Baldwin DS, Florea I, Jacobsen PL, Zhong W, Nomikos GG.

J Affect Disord. 2016 Jul 7;206:140-150. doi: 10.1016/j.jad.2016.07.015. [Epub ahead of print]

5.

Which factors influence onset and latency to treatment in generalized anxiety disorder, panic disorder, and obsessive-compulsive disorder?

Benatti B, Camuri G, Dell'Osso B, Cremaschi L, Sembira E, Palazzo C, Oldani L, Dobrea C, Arici C, Primavera D, Carpiniello B, Castellano F, CarrĂ  G, Clerici M, Baldwin DS, Altamura AC.

Int Clin Psychopharmacol. 2016 Jul 4. [Epub ahead of print]

PMID:
27384739
6.

Altruism, personal benefit, and anxieties: a phenomenological study of healthy volunteers' experiences in a placebo-controlled trial of duloxetine.

Kwakye IN, Garner M, Baldwin DS, Bamford S, Pinkney V, Bishop FL.

Hum Psychopharmacol. 2016 Jul;31(4):332-40. doi: 10.1002/hup.2543.

7.

Genetic mechanisms of electroconvulsive therapy response in depression.

Benson-Martin JJ, Stein DJ, Baldwin DS, Domschke K.

Hum Psychopharmacol. 2016 May;31(3):247-51. doi: 10.1002/hup.2531. Epub 2016 Apr 6.

PMID:
27062668
8.

Safety and Tolerability of Pharmacological Treatment of Alcohol Dependence: Comprehensive Review of Evidence.

Sinclair JM, Chambers SE, Shiles CJ, Baldwin DS.

Drug Saf. 2016 Jul;39(7):627-45. doi: 10.1007/s40264-016-0416-y. Review.

PMID:
27023898
9.

Efficacy of escitalopram in the treatment of social anxiety disorder: A meta-analysis versus placebo.

Baldwin DS, Asakura S, Koyama T, Hayano T, Hagino A, Reines E, Larsen K.

Eur Neuropsychopharmacol. 2016 Jun;26(6):1062-9. doi: 10.1016/j.euroneuro.2016.02.013. Epub 2016 Feb 27.

10.

The safety and tolerability of vortioxetine: Analysis of data from randomized placebo-controlled trials and open-label extension studies.

Baldwin DS, Chrones L, Florea I, Nielsen R, Nomikos GG, Palo W, Reines E.

J Psychopharmacol. 2016 Mar;30(3):242-52. doi: 10.1177/0269881116628440. Epub 2016 Feb 9.

11.

Pharmacology for sleep disturbance in PTSD.

Lipinska G, Baldwin DS, Thomas KG.

Hum Psychopharmacol. 2016 Mar;31(2):156-63. doi: 10.1002/hup.2522. Epub 2016 Feb 8.

PMID:
26856810
12.

The severity of sediment desiccation affects the adsorption characteristics and speciation of phosphorus.

Attygalla NW, Baldwin DS, Silvester E, Kappen P, Whitworth KL.

Environ Sci Process Impacts. 2016 Jan;18(1):64-71. doi: 10.1039/c5em00523j.

PMID:
26686223
13.

Does previous experience of antidepressants form the expectations necessary for a placebo response?

Huneke NT, Baldwin DS.

Br J Psychiatry. 2015 Dec;207(6):561. doi: 10.1192/bjp.207.6.561a. No abstract available.

PMID:
26628699
14.

Impact of Antidepressant Drugs on Sexual Function and Satisfaction.

Baldwin DS, Manson C, Nowak M.

CNS Drugs. 2015 Nov;29(11):905-13. doi: 10.1007/s40263-015-0294-3. Review.

PMID:
26519341
15.

Altered executive control network resting-state connectivity in social anxiety disorder.

Geiger MJ, Domschke K, Ipser J, Hattingh C, Baldwin DS, Lochner C, Stein DJ.

World J Biol Psychiatry. 2016;17(1):47-57. doi: 10.3109/15622975.2015.1083613. Epub 2015 Oct 9.

PMID:
26452782
16.

Daytime intrusive thoughts and subjective insomnia symptoms.

Baker LD, Baldwin DS, Garner M.

Psychiatry Res. 2015 Oct 30;229(3):1038-42. doi: 10.1016/j.psychres.2015.02.022. Epub 2015 Mar 31.

PMID:
26279126
17.

Can cognitive behaviour therapy beneficially influence arousal mechanisms in psychosis?

Howells FM, Baldwin DS, Kingdon DG.

Hum Psychopharmacol. 2016 Jan;31(1):64-9. doi: 10.1002/hup.2499. Epub 2015 Aug 13.

PMID:
26270489
18.

Efficacy and safety of pregabalin in generalised anxiety disorder: A critical review of the literature.

Baldwin DS, den Boer JA, Lyndon G, Emir B, Schweizer E, Haswell H.

J Psychopharmacol. 2015 Oct;29(10):1047-60. doi: 10.1177/0269881115598411. Epub 2015 Aug 10. Review.

PMID:
26259772
19.

Transcranial direct current stimulation (tDCS) in the treatment of depression: Systematic review and meta-analysis of efficacy and tolerability.

Meron D, Hedger N, Garner M, Baldwin DS.

Neurosci Biobehav Rev. 2015 Oct;57:46-62. doi: 10.1016/j.neubiorev.2015.07.012. Epub 2015 Jul 29. Review.

PMID:
26232699
20.

A systematic review of the predictors of health service utilisation by adults with mental disorders in the UK.

Twomey CD, Baldwin DS, Hopfe M, Cieza A.

BMJ Open. 2015 Jul 6;5(7):e007575. doi: 10.1136/bmjopen-2015-007575. Review.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk